Leptin and paraoxonase activity in cord blood from obese mothers

References

• Codoñer-Franch P, Valls-Bellés V, Arilla-Codoñer A, Alonso-Iglesias E. Oxidant mechanisms in childhood obesity: the link between inflammation and oxidative stress. Transl Res 2011;158:369–84
   PubMed Web of Science ®Google Scholar
• Atabek ME, Vatansev H, Erkul I. Oxidative stress in childhood obesity. J Pediatr Endocrinol Metab 2004;17:1063–8
   PubMedGoogle Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752–61
   PubMed Web of Science ®Google Scholar
• Ferretti G, Bacchetti T, Masciangelo S, Bicchiega V. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects. Obesity 2010;18:1079–84
   PubMed Web of Science ®Google Scholar
• Savini I, Catani MV, Evangelista D, et al. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 2013;14:10497–538
   PubMed Web of Science ®Google Scholar
• Joint FAO/WHO expert consultation on diet, nutrition and the prevention of chronic diseases. Diet, nutrition, and the prevention of chronic diseases. World Health Organ Tech Rep Ser 2003;916:58–63
   Google Scholar
• Li M, Sloboda DM, Vickers MH. Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Experiment Diabetes Res 2011;2011:9. Article ID. 592408. doi: 10.1155/2011/592408
   Google Scholar
• Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991;286:152–4
   PubMed Web of Science ®Google Scholar
• Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993;104:129–35
   PubMed Web of Science ®Google Scholar
• Mackness B, Mackness M. Anti-inflammatory properties of paraoxonase-1 in atherosclerosis. Adv Exp Med Biol 2010;660:143–51
   PubMed Web of Science ®Google Scholar
• Mastorikou M, Mackness B, Liu Y, Mackness M. Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides. Diabet Med 2008;25:1049–55
   PubMed Web of Science ®Google Scholar
• Navab M, Imes SS, Hama SY, et al. Monocyte transmigration induced by modification of low density lipoprotein in co-cultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991;88:2039–46
   PubMed Web of Science ®Google Scholar
• Mackness B, Hine D, Liu Y, et al. Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochem Biophys Res Commun 2004;318:680–3
   PubMed Web of Science ®Google Scholar
• Ferretti G, Bacchetti T, Masciangelo S, et al. Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome. Dis Model Mech 2012;5:698–705
   PubMed Web of Science ®Google Scholar
• Ferretti G, Bacchetti T, Moroni C, et al. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab 2005;90:1728–33
   PubMed Web of Science ®Google Scholar
• Krzystek-Korpacka M, Patryn E, Hotowy K, et al. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress. Adv Clin Exp Med 2013;22:229--236
   PubMedGoogle Scholar
• Payne GA, Tune JD, Knudson JD. Leptin-induced endothelial dysfunction: a target for therapeutic interventions. Curr Pharm Des 2013 [Epub ahead of print]
   Google Scholar
• Lepercq J, Hauguel De Mouzo S. Leptin during pregnancy. J Gynecol Obstet Biol Reprod (Paris) 2002;31:167–72
   PubMedGoogle Scholar
• Lepercq J, Challier JC, Guerre-Millo M, et al. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 2001;86:2409–13
   PubMed Web of Science ®Google Scholar
• Holvoet P, Stassen JM, Van Cleemput J, et al. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18:100–7
   PubMedGoogle Scholar
• Matsuda J, Yokota I, Iida M, et al. Serum leptin concentration in cord blood: relationship to birth weight and gender. J Clin Endocrinol Metab 1997;8:1642–4
   Google Scholar
• Abuhandan M, Cakmak A, Taskın A, et al. The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants. J Clin Lab Anal 2012;26:302–6
   PubMedGoogle Scholar
• Gelisgen R, Genc H, Kayali R, et al. Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res Clin Pract 2011;94:404–9
   PubMed Web of Science ®Google Scholar
• Stefanović A, Ardalic D, Kotur-Stevuljević J, et al. Longitudinal changes in PON1 activities, PON1 phenotype distribution and oxidative status throughout normal pregnancy. Reprod Toxicol 2012;33:20–6
   PubMedGoogle Scholar
• Bastida S, Sánchez-Muniz FJ, Cuesta C, et al. Male and female cord blood lipoprotein profile differences throughout the term-period. J Perinat Med 1997;25:184–91
   PubMedGoogle Scholar
• Dolphin PJ, Breckenridge WC, Dolphin MA, Tan MH. The lipoproteins of human umbilical cord blood apolipoprotein and lipid levels. Atherosclerosis 1984;51:109–22
   PubMed Web of Science ®Google Scholar
• Sreckovic I, Birner-Gruenberger R, Obrist B, et al. Distinct composition of human fetal HDL attenuates its anti-oxidative capacity. Biochim Biophys Acta 2013;1831:737–46
   PubMed Web of Science ®Google Scholar
• Sivan E, Mazaki-Tovi S, Pariente C, et al. Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab 2003;88:5656–60
   PubMed Web of Science ®Google Scholar
• Weyermann M, Beermann C, Brenner H, Rothenbacher D. Adiponectin and leptin in maternal serum, cord blood, and breast milk. Clin Chem 2006;52:2095–102
   PubMed Web of Science ®Google Scholar
• Brynhildsen J, Sydsjö G, Blomberg M, et al. Leptin and adiponectin in cord blood from children of normal weight, overweight and obese mothers. Acta Paediatr 2013;102:620–4
   PubMedGoogle Scholar
• Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155–61
   PubMed Web of Science ®Google Scholar
• Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:12–22
   PubMed Web of Science ®Google Scholar
• Yamagishi SI, Edelstein D, Du XL, et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001;276:25096–100
   PubMed Web of Science ®Google Scholar
• Beltowski J, Wojcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for roatherogenic effect of chronic hyperleptinemia. Atherosclerosis 2003;170:21--29
   PubMed Web of Science ®Google Scholar